Skip to main content
. 2022 Jun 9;17(6):e0268780. doi: 10.1371/journal.pone.0268780

Fig 1. Proportion of patients with anti-S after two Covid-19 mRNA doses.

Fig 1

Proportion of patients with humoral immune response to SARS-CoV-2 spike protein (anti-S) are shown in total and for various subgroups (Anti-SARS-CoV-2 spike protein antibodies cutoff >12 AU/ml). Baseline IgG values indicate the severity of the humoral immunodeficiency disease at start of immunoglobulin replacement therapy. P values are calculated by Chi-square test. Anti-SARS-CoV-2 spike protein antibodies (anti-S).